BioButton Device for Walking Problems

Recruiting in Palo Alto (17 mi)

Overseen ByCharles Lin, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Charles Lin

No Placebo Group

Trial Summary

What is the purpose of this trial?This pilot study will explore the use of the BioIntellisense BioButton, a remote wearable multi-parameter monitor, to identify gait disturbances that occur as a side effect of polypharmacy.

Eligibility Criteria

This trial is for adults over 18 who have documented gait issues in their medical records. It's not suitable for non-English speakers, those unable to consent due to cognitive problems, or individuals who are bedbound or can't stand.

Inclusion Criteria

I am older than 18 years.

Exclusion Criteria

I am bedbound and cannot stand up.

I am under 18 years old.

I am unable to give consent because of my cognitive condition.

Participant Groups

The study tests the BioIntellisense BioButton, a wearable device that monitors various health parameters to detect gait disturbances caused by taking multiple medications.

2Treatment groups

Experimental Treatment

Group I: Patient GroupExperimental Treatment1 Intervention

Patients in this arm will wear the device, BioButton, continuous for 30 days as it collects physiologic and gait data, while receiving otherwise routine, standard of care.

Group II: Nurse GroupExperimental Treatment1 Intervention

Nurses caring for patients wearing the device, BioButton, will assist in placing and removing the device. Otherwise, they will provide routine, standard of care to the enrolled patients to determine the overall feasibility of the device for clinical care providers.